Academic Journal
Q1Calcified Tissue International
About Calcified Tissue International
About Calcified Tissue International
Calcified Tissue International is a peer-reviewed scholarly journal published by Springer (United States). It focuses on Q1. Publication coverage spans 1973, 1976-1977, 1979-2026.
Key indicators: ISSN 1432-0827, 0171-967X; H-index 140.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (140): Exceptionally high — 140 articles have each been cited at least 140 times. This indicates deep, sustained influence in the field.
Publishing in Calcified Tissue International
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Calcified Tissue International?
1432-0827, 0171-967X.
Who publishes Calcified Tissue International?
Springer.
What are Calcified Tissue International's metrics?
H-index 140.
Is Calcified Tissue International peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Bone health and osteoporosis research; Bone health and treatments; Bone Metabolism and Diseases; Vitamin D Research Studies; Parathyroid Disorders and Treatments; Bone and Dental Protein Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,990.00 USD; 2,990.00 EUR; 2,590.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
From Association to Treatment Threshold: Interpreting Burosumab Dose and HRQoL in Pediatric X-Linked Hypophosphatemia
Ercan Yılmaz, Zeynep Yamancan Yılmaz
2026-10-15 · DOI: 10.1007/s00223-026-01623-6Correction to: Improvement of Bone Healing by Combined Treatment with Selective Androgen and Estrogen Receptor Modulators in Female and Male Rats
Marina Komrakova, Fabian Nicolai Brunnert, Christian Anders, Kai Oliver Böker et al.
2026-10-10 · DOI: 10.1007/s00223-026-01609-4Trabecular Bone Score has Limited Ability to Discriminate Fragility Fractures in Postmenopausal Women with Osteopenia: A Danish Case-Control Study
Vivi-Nelli Mäkinen, Amalie Lyngberg, Anne Sophie Sølling, Torben Harsløf et al.
2026-10-10 · DOI: 10.1007/s00223-026-01621-8A Clinical Primer on Computer Vision
Jon Parkinson, Claudia Lindner
2026-10-07 · DOI: 10.1007/s00223-026-01620-9Correction: Water Fluoridation Risks or Benefits: Summary of the Symposium Presented During the Enamel 11 Meeting Held in Paris France
Sylvie Babajko, Marilia Buzalaf, Jean-Baptiste Fini, Pamela Den Besten et al.
2026-10-07 · DOI: 10.1007/s00223-026-01601-yCardiovascular Morbidity and Mortality in Chronic Hypoparathyroidism: A Systematic Review and Meta-Analysis
Deep Dutta, Kunal Mahajan, Ashima Mittal, Oscar R. Rivera et al.
2026-10-05 · DOI: 10.1007/s00223-026-01617-4Romosozumab Prescribing in Relation to Cardiovascular Disease History in Japan: A Nationwide Claims Database Study
Yuki Fujita, Katsuyasu Kouda, Kenji Fujimori, Nobukazu Okimoto et al.
2026-10-03 · DOI: 10.1007/s00223-026-01613-8Objective Physical Performance Predicts 10-Year Fracture Risk Without Densitometry in Older Men and Women: Development and Head-to-Head Comparison with FRAX in MrOS and SOF
Filipe R. Carvalho, Paulo J. Gavaia
2026-10-01 · DOI: 10.1007/s00223-026-01618-3Generation and Characterization of an Osteoclastic Cell Model of Gaucher’s Bone Disease
Juan-David Patiño-Salazar, Juan Diego Gutiérrez-Ávila, Sara Heredero-Jimenez, Eduardo Martín-Guerrero et al.
2026-10-01 · DOI: 10.1007/s00223-026-01616-5Osteosarcopenia: More Than the Sum of Its Parts? A Community-Based Study Across Sarcopenia Definitions
Radmila Matijevic, Milan Tosic, Filip Lazetic, Nikola Vukosav et al.
2026-10-01 · DOI: 10.1007/s00223-026-01611-wDivergent trajectories of structural accrual and matrix-level mechanical properties during alveolar bone maturation
Jun Zhou, Xiaoling Liao, Jingxiao Zhong, Li Zhou et al.
2026-10-01 · DOI: 10.1007/s00223-026-01615-6Fracture Risk Stratification by REMS: A 5 Years Prospective Longitudinal Multicentre Study
Carla Caffarelli, Maria Luisa Brandi, Giuseppe Girasole, Andrea Giusti et al.
2026-10-01 · DOI: 10.1007/s00223-026-01610-xCalcitonin Gene-Related Peptide (CGRP) in Bone Repair and Musculoskeletal Pain: A Scoping Review of Skeletal Regeneration, Joint and Tendon Involvement, and CGRP-Targeted Therapies
Surakshya Baral, Sanyam Kulshrestha, Vibhu Krishnan Viswanathan, Vijay Kumar Jain et al.
2026-10-01 · DOI: 10.1007/s00223-026-01619-2Equivalent Twelve-Month Bone Mineral Density Response to Romosozumab in Patients Aged ≥ 85 Years and < 85 Years: A Multi-center Real-World Cohort Study (n = 417) from Northern Japan
Ryo Nakano, Atsushi Suzuki, Hiroki Iwasaki, Akira Fukuda et al.
2026-09-25 · DOI: 10.1007/s00223-026-01600-zLow Prevalence of Exploratory Biochemical Patterns Compatible with Osteomalacia in a Large Cohort of Participants with Low Serum 25-Hydroxyvitamin D Levels
Rolf Jorde, Per Medbøe Thorsby, Guri Grimnes
2026-09-23 · DOI: 10.1007/s00223-026-01612-9Osteoporosis and Skeletal Fragility in non-Metastatic Pheochromocytomas and Paragangliomas: The Adrenergic-Skeletal Axis
Alberto Vassallo, Filippo Raggini
2026-09-18 · DOI: 10.1007/s00223-026-01607-6Anti-osteoporotic Pharmacotherapy and Muscle Outcomes in Osteosarcopenia: a Source-Verified Translational Evidence Map
Dong-Ju Lim, Min Kue Kang
2026-09-18 · DOI: 10.1007/s00223-026-01608-5Associations Between Peripheral Blood Inflammatory and Immune Markers and Osteoporotic and Fragility Fractures: A Systematic Review and Meta-Analysis
Chenyang Li, Chenbing Zhao, Ruhui Fu, Shangkun Zhong et al.
2026-09-18 · DOI: 10.1007/s00223-026-01606-7Somatic Mosaicism Modulating Clinical Severity in COL2A1-Related Skeletal Dysplasia: A Case of Profound Skeletal Asymmetry
Rukiye Sena Turk Yilmaz, Lisa Cruz, Cemre Robinson, Allen E. Bale et al.
2026-09-18 · DOI: 10.1007/s00223-026-01599-3Association of Serum Parathyroid Hormone Levels with All-Cause and Cause-Specific Mortality Among U.S. Adults, with a Focus on the Parathyroid Hormone Levels Within the Normal Range: a Population-Based Cohort Study from NHANES 2003–2006
Xiao-chun Cheng, Li-yuan Mu, Ze Wang, Hao Li et al.
2026-09-16 · DOI: 10.1007/s00223-026-01604-9Reviews
Community Reviews
Version History
October 9, 2026 at 7:46 pm
September 25, 2026